RESPICENTRAL(TM)— 510(k) K863538

Name: FDA 510(k) clearance K863538
Creator: U.S. Food and Drug Administration
Published: 1986-09-24

Substantially Equivalent

Dickstein, Shapiro & Morin

FDA 510(k) clearance K863538 for RESPICENTRAL(TM), Substantially Equivalent on 1986-09-24. Applicant: Dickstein, Shapiro & Morin. Device class: 2.

Clearance details

Applicant: Dickstein, Shapiro & Morin
Product code: Code BZK
Device class: Class 2
Regulation: 21 CFR 868.1850
Advisory panel: Anesthesiology
Date received: 1986-09-11
Decision date: 1986-09-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code BZK

view all

K192584 — BEACON Caresystem Model 000021442019-12-18
K192595 — ExSpiron 2Xi2019-12-17
K180788 — Gas Module 32018-10-24
K173181 — ExSpiron 1Xi2018-03-16
K162131 — ExSpiron 1Xi2017-05-09

More clearances from Dickstein, Shapiro & Morin

view all

K861326 — RESPISOMNOGRAPH1986-06-13

Adverse events under product code BZK

product code BZK

Death: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.